National Cancer Institute (NCI) researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of ...
A simple blood test may be able to notify patients and their health care providers if their oropharyngeal cancer is recurring. A recent study conducted at the University of Michigan Health System ...
PASADENA, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by OmniPathology, please note that the second sentence in paragraph one should read "The ...
However, the test for antibodies against HPV16 E6 is not suitable for assessing the risk for cervical cancer and other HPV-associated cancers in genital areas. As opposed to cancer of the oropharynx, ...
WALTHAM, Mass.--(BUSINESS WIRE)--Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the presentation of new data at the 66th Annual Meeting of the ...
Please provide your email address to receive an email when new articles are posted on . A novel noninvasive droplet digital polymerase chain reaction-based assay predicted treatment response months ...
A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma (OPSCC) ...
PASADENA, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- OmniPathology, an independent, physician-owned and operated pathology lab, today announced the launch of a new oral test for human papillomavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback